fr

Successful first “Aeson® European User Meeting”, marking an important step in the deployment of CARMAT’s artificial heart

CARMAT expands its PIVOTAL study internationally, in line with its clinical strategy and CE marking process

Download

2017 half-year results

Download

CARMAT appoints Francesco Arecchi, previously Product Manager EMEA Structural Heart at Abbott, as Marketing Manager

Download

CARMAT appoints Wenzel Hurtak as Director of Manufacturing

Download

CARMAT announces the resumption of the PIVOTAL study in France

Download

2016 full-year results

Download

CARMAT provides an update regarding the suspended PIVOTAL study on its bioprosthetic artificial heart

Download

Two cardiology experts join CARMAT’s Board of Directors as independent members

Download
Top of page